Healthy AdultsNCT03586349
Cultural Adaptation of Sedentary Behavior Questionnaire and Reliability, Validity Research of Turkish Version
An observational study of Healthy Adults, run by Begum Kara Kaya at 1 site in Turkey (Türkiye).
Trial summary
The aim of this study is to adapt the Sedentary Behavior Questionnaire (SBQ) into the culture of Turkish and to work on the reliability and validity of it in healthy individuals between the ages of 18-64. Read more about this study
- Who is it for?
- Ages 18 to 64 yearsHealthy volunteers can take part
- Conditions the study is for
- Healthy Adults
- How many people
- 210 participants
- Where
- 1 siteTurkey (Türkiye)
- Study dates
- 1 Jan 2018to 30 Sep 2018
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 64 years
- All sexes
- Healthy volunteers accepted
- Adult
Study population: Healthy adults aged between 18-64 years.
Who may be able to join
- Being a healthy individual between the ages of 18-64.
- No problem of reading, writing or understanding Turkish.
Who cannot join
- Severe trauma in the last 6 months.
- Having orthopedic, neurological, cardiovascular problems that restricts ambulation.
Trial locations and contacts
1 site in 1 country.
About this study
The aim of this study is to adapt the Sedentary Behavior Questionnaire (SBQ) into the culture of Turkish and to work on the reliability and validity of it in healthy individuals between the ages of 18-64. The permission was obtained via mail from Dori Rosenberg, who is the developer of the questionnaire, for its Turkish adaptation. SPSS package programme will be used in the analysis,
Read the detailed description
The aim of this study is to adapt the Sedentary Behavior Questionnaire (SBQ) into the culture of Turkish and to work on the reliability and validity of it in healthy individuals between the ages of 18-64. Original form has nine questions but Spanish version of it had eleven questions so the investigators will translate Spanish version of SBQ. At first step by using a forward-backward translation method, a translation and adaptation process will be performed. At second step the validation process will be performed in a total of 200 healthy subjects aged between 18-64 years. Subjects will fill sociodemographic information form, International Physical Activity Questionnaire Short Form, and SBQ Turkish version ( at baseline and after seven days). Cronbach's alpha values, confirmatory factor analysis (CFA) will be evaluated for the reliability, construct and convergent validity.
- Conditions
- Healthy Adults
What is being measured
The primary outcome is the main question the study is designed to answer.
Sedentary Behavior Questionnaire
Sedentary Behavior Questionnaire scales the amount of time spent doing 11 sedentary behaviors.Response options are none, 15 minutes or less, 30 minutes, 1 hour, 2 hours,3 hours, 4 hours, 5 hours, 6 hours or more. In the scoring the time spent on each behavior is converted into hours (eg, a response of 15 minutes is recoded as .25 hours). For the total scores of sedentary behavior, responsed hours per day for each behavior are summed separately for weekday and weekend days. For the summary scores of total hours/day spent in sedentary behaviors (weekday and weekend) and total sedentary hours/week, responses higher than 24 hours/day are truncated to 24 hours/day. There are not any normative variables of Sedentary Behavior Questionnaire.
Measured: 1 week
Secondary outcomes (1)
International Physical Activity Questionnaire Short Form
International Physical Activity Questionnaire Short Form(IPAQ-SF) scales the types of intensity of physical activity and sitting time that people do as part of their daily lives. The short form records the physical activity of 3 different intensity levels: 1) vigorous-intensity activity such as aerobics (8.0 MET), 2) moderate-intensity activity such as leisure cycling (4.0 MET), 3) walking (3.3 MET). The IPAQ-SF questions activities for last 7 days with 7 items. In the scoring total estimate physical activity in MET-min/week and time spent while sitting are calculated ( Ex. 4.0 METx activity dayx activity duration (in minutes) equals moderate-intensity activity total MET score).According to scores subjects are categorized as inactive (achieving <600 MET-min/week), minimally active (achieving a minimum of at least 600 MET-min/week and <3000 MET-min/week), active (>3000 MET-min/week).
Measured: Day 1
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted13 Jul 2018
- Study start1 Jan 2018
- Primary completion1 Jul 2018
- Study completion30 Sep 2018
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Healthy AdultsStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Other
- Time perspective
- Prospective
- Enrolment
- 210 participants (actual)
Sponsor and investigators
- Lead sponsor
- Begum Kara Kaya
- Sponsor type
- University, hospital or other
- Collaborators
- Istanbul University
- Responsible party
- Sponsor-investigator, Begum Kara Kaya, Biruni University
- Investigators
- Ayse Zengin Alpozgen, Principal investigator, Istanbul University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT03586349
- Sponsor's protocol ID
- Study
- Status last verified
- Jul 2018
- First submitted
- 2 Jul 2018
- Last updated
- 16 Jan 2019
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
Study at a glance
From the registry record, last updated by the sponsor on 16 Jan 2019. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Cultural Adaptation of Sedentary Behavior Questionnaire and Reliability, Validity Research of Turkish Version
- ClinicalTrials.gov ID
- NCT03586349
- Acronym / sponsor ID
- Study
- Conditions
- Healthy Adults
- Study type
- Observational
- Recruitment status
- Completed
- Enrolment
- 210 participants (actual)
- Lead sponsor
- Begum Kara KayaUniversity, hospital or other
- Collaborators
- Istanbul University
- Study start
- 1 Jan 2018 (actual)
- Primary completion
- 1 Jul 2018 (actual)
- Study completion
- 30 Sep 2018 (actual)
- First posted
- 13 Jul 2018 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The aim of this study is to adapt the Sedentary Behavior Questionnaire (SBQ) into the culture of Turkish and to work on the reliability and validity of it in healthy individuals between the ages of 18-64. The permission was obtained via mail from Dori Rosenberg, who is the developer of the questionnaire, for its Turkish adaptation. SPSS package programme will be used in the analysis,
Detailed description
The aim of this study is to adapt the Sedentary Behavior Questionnaire (SBQ) into the culture of Turkish and to work on the reliability and validity of it in healthy individuals between the ages of 18-64. Original form has nine questions but Spanish version of it had eleven questions so the investigators will translate Spanish version of SBQ. At first step by using a forward-backward translation method, a translation and adaptation process will be performed. At second step the validation process will be performed in a total of 200 healthy subjects aged between 18-64 years. Subjects will fill sociodemographic information form, International Physical Activity Questionnaire Short Form, and SBQ Turkish version ( at baseline and after seven days). Cronbach's alpha values, confirmatory factor analysis (CFA) will be evaluated for the reliability, construct and convergent validity.
Study design
- Observational model
- Other
- Time perspective
- Prospective
Who may qualify
- Ages
- 18 to 64 years
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult
- Study population
- Healthy adults aged between 18-64 years.
Key inclusion criteria (2 listed)
- Being a healthy individual between the ages of 18-64.
- No problem of reading, writing or understanding Turkish.
Key exclusion criteria (2 listed)
- Severe trauma in the last 6 months.
- Having orthopedic, neurological, cardiovascular problems that restricts ambulation.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Primary outcome
Sedentary Behavior Questionnaire
Time frame: 1 week
Sedentary Behavior Questionnaire scales the amount of time spent doing 11 sedentary behaviors.Response options are none, 15 minutes or less, 30 minutes, 1 hour, 2 hours,3 hours, 4 hours, 5 hours, 6 hours or more. In the scoring the time spent on each behavior is converted into hours (eg, a response of 15 minutes is recoded as .25 hours). For the total scores of sedentary behavior, responsed hours per day for each behavior are summed separately for weekday and weekend days. For the summary scores of total hours/day spent in sedentary behaviors (weekday and weekend) and total sedentary hours/week, responses higher than 24 hours/day are truncated to 24 hours/day. There are not any normative variables of Sedentary Behavior Questionnaire.
1 secondary outcome
International Physical Activity Questionnaire Short Form
Time frame: Day 1
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 16 Jan 2019.
Related trials for Healthy Adults
Not yet recruitingPhase 1
A Phase I Study of GLR2053 Tablets in Chinese Healthy Adult Participants
Atopic Dermatitis
RecruitingPhase 1
First-in-Human Trial to Assess REGN20423 in Healthy Adult Participants and Adult Participants With Atopic Dermatitis
Healthy Volunteer, Atopic Dermatitis
Not yet recruitingPhase 1/2
Clinical Trial to Assess the Safety, Tolerability, Reactogenicity, and Immunogenicity of a 10 Valent Human Papillomavirus Virus (10vHPV) Vaccine
Human Papillomavirus Infection
Not yet recruiting
REM Enhancement Sleep Technology for Well-being, Emotion, and Life Lift
Healthy Adult Participants
Not yet recruitingPhase 1
Safety and Immunogenicity of Chimeric Hemagglutinin mRNA Vaccine Candidates
Influenza
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Ayse Zengin Alpozgen principal investigator
Istanbul University
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Healthy Adults, run by Begum Kara Kaya at 1 site in Turkey (Türkiye).
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 2 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 16 Jan 2019. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Sedentary Behavior Questionnaire (time frame: 1 week). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 16 Jan 2019.